Table 3 Correlation between SGOL2 expression and clinicopathological characteristics in Cohort 1/2
|  | Cohort 1 (n = 100) | Cohort 2 (n = 102) |
|---|---|---|
Characteristics | No. of patients (%) | No. of patients (%) |
Gender | ||
 Male | 86 (86.0%) | 81 (79.41%) |
 Female | 14 (14.0%) | 21 (20.59%) |
Age | ||
  ≤ 58 | 50 (50.0%) | 45 (44.12%) |
  > 58 | 50 (50.0%) | 57 (55.88%) |
Liver cirrhosis history | ||
 Yes | 21 (21.0%) | 65 (63.73%) |
 No | 73 (73.0%) | 37 (36.27%) |
 Null | 6 (6.0%) | |
TNM stages | ||
 I/II | 63 (63.3%) | 57 (55.88%) |
 III/IV | 37 (37.0%) | 45 (44.12%) |